Safety and Efficacy of Combined Trabectedin and Pegylated Liposomal Doxorubicin Therapy for Recurrent Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 3 Randomized, Open-Label, Multicenter Trial for Safety and Efficacy of Combined Trabectedin and Pegylated Liposomal Doxorubicin Therapy for Recurrent Ovarian Cancer
Gynecol. Oncol 2020 Jan 08;[EPub Ahead of Print], BJ Monk, TJ Herzog, G Wang, S Triantos, S Maul, R Knoblauch, T McGowan, WSW Shalaby, RL ColemanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.